Imaging in MM: What Is the Role of Imaging in Plasma Cell Dyscrasias? WBLDCT, PET/CT, MRI - When to Choose Each Option? How Can We Evaluate Therapy Response?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Imaging in MM: What Is the Role of Imaging in Plasma Cell Dyscrasias? WBLDCT, PET/CT, MRI - When to Choose Each Option? How Can We Evaluate Therapy Response?

By 2nd SOHO Italian Conference FEATURING Elena Zamagni

11 views

January 25, 2021

0 Comments

Treatment-Related Quality of Life in MF

Feat. A. Hunter

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

Feat. K. Sidor

45:43

MedNews Week

Multiple Myeloma in 2022: Developments, Directions, and Disparities

Feat. J. Mikhael

26:10

MyCancerHaven

Multiple Myeloma 101: Epidemiology, Diagnosis and Staging

Feat. R. Vij, S. Kumar

43:50

MyCancerHaven

The Basics of Diagnostic Testing in Multiple Myeloma: How to Interpr…

Feat. R. Vij, C. Emmitt Cole

11:18

5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Manage Bone Disease and its Complications in …

Feat. E. Terpos

36:59

Dana-Farber Cancer Institute

Updates on Managing Bone Disease in Multiple Myeloma

Feat. M. Hartley-Brown

13:03

Roswell Park Comprehensive Cancer Center

Bone Imaging Techniques in MM

Feat. J. Hillengass

13:22

SOHO 3rd Italian Conference

SOHO Italy 2021 on the Importance of Imaging in Novel Agents' E…

Feat. E. Zamagni

17:17

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Emerging Data on Management and Imaging of Myeloma Bone Disease

Feat. M. Dimopoulos

09:34

SOHO Italy 1st School of Multiple Myeloma

Comparison of Different Imaging Techniques in MM: Whole-Body Compute…

Feat. S. Grammatico

17:37

Roswell Park Comprehensive Cancer Center

Bone Marrow Imaging Techniques in MM

Feat. J. Hillengass

15:54

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

MRD in Newly Diagnosed MM: MRI vs. PET/CT, RVD+/-ASCT, Dara+Len to R…

Feat. E. Terpos

14:12

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Myeloma Bone Disease and Management: Optimal Imaging Supports Clinic…

Feat. M. Drake

06:26

Ravi Vij

Surveillance After Initial Therapy in Myeloma

10:15

Ravi Vij

Practical Use of Imaging From MGUS to Myeloma

25:23

Houston Methodist Hospital

Whole-Body MRI: Past, Present, and Future

Feat. N. Gupta

21:05

Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale

17:46

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies …

Feat. A. Jakubowiak

16:42

Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…

Feat. H. Hashmi

19:24

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - In…

Feat. P. Richardson

Login

Login

Join VuMedi

Imaging in MM: What Is the Role of Imaging in Plasma Cell Dyscrasias? WBLDCT, PET/CT, MRI - When to Choose Each Option? How Can We Evaluate Therapy Response?

Related Content